Ambria Capital is an investment firm that manages its own money and invests in pre-Series A psychedelic companies.
Ambria
Ambria was founded in 2018 by Michael Sobeck, who’s also the founder of the Perception Restoration Foundation, a non-profit dedicated to the treatment of HPPD.
The fund has invested in more than 20 psychedelic companies, including atai and Small Pharma.
Activities
B2B
Investor
Explore more company info with a Tree membership
📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates